ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Ajanta Pharma submitted its Annual Secretarial Compliance Report for the year ended March 2026. This routine regulatory filing confirms adherence to SEBI listing obligations and disclosure requirements.
Ajanta Pharma's promoters have submitted a declaration under SEBI Takeover Regulations for the financial year ended March 31, 2026. The filing confirms that no new direct or indirect encumbrances were made on promoter shares during the year, other than those already disclosed.